Agile’s business strategy is to build a pipeline of women’s health products. The Company’s lead product within its pipeline is a low dose, once-weekly contraceptive patch utilizing Agile’s unique, proprietary technology. This formulation and design technology enables a matrix transdermal patch to deliver hormones with low skin permeation such as levonorgestrel and ethinyl estradiol in levels high enough to achieve effective contraception.

Agile plans to capitalize on its patented transdermal expertise to extend the product franchise with other contraceptive offerings. In addition, the company is pursuing other in-license opportunities within the women’s healthcare market.